Results 21 to 30 of about 335,762 (303)
Development of a novel equine influenza virus live-attenuated vaccine [PDF]
, 2018 H3N8 equine influenza virus (EIV) is an important and significant respiratory pathogen of horses. EIV is enzootic in Europe and North America, mainly due to the suboptimal efficacy of current vaccines. We describe, for the first time, the generation of a
Chambers, Thomas M. +5 more
core +1 more source
Progress and problems in vaccination against necrotic enteritis in broiler chickens [PDF]
, 2014 Necrotic enteritis in broilers is caused by Clostridium perfringens type A strains that produce the NetB toxin. Necrotic enteritis is one of the gastrointestinal diseases in poultry that has gained worldwide importance during the last decade due to ...
Ducatelle, Richard +4 more
core +2 more sources
Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. [PDF]
, 2015 The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve this aim, it is essential to block viral replication in individuals via induction of a robust mucosal immune response. Although it has long been recognized
Anis E +16 more
core +3 more sources
Post vaccinal temporary sensorineural hearing loss [PDF]
, 2018 In our systematic research we identified four studies concerning the onset of neurological adverse events following vaccination and two excluding this association.
De Cesare, Donato Pompeo +8 more
core +1 more source
Current Approaches to Develop a Live Vaccine against Leishmania majo
Novelty in Biomedicine, 2017 Leishmaniasis is an infectious disease that is endemic in 88 countries. Most of the patients after recovery from the infection develop a long-lived natural immunity against re-infection.
Farshid Yeganeh +1 more
doaj +1 more source
Genomic Characteristics of a Chicken Infectious Anemia Virus in Contaminated Attenuated Vaccine
Frontiers in Veterinary Science, 2022 Chicken infectious anemia virus (CIAV) can be transmitted by contaminated live vaccines, and causes huge economic losses. This study evaluated the contamination status of CIAV in 24 batches of vaccines by recombinase-aided amplification assay (RAA ...
Longfei Chen +23 more
doaj +1 more source
Vaccines against toxoplasma gondii : challenges and opportunities [PDF]
, 2009 Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J +117 more
core +3 more sources
A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus [PDF]
, 2014 Bluetongue is one of the major infectious diseases of ruminants and is caused by Bluetongue virus (BTV), an arbovirus existing in nature in at least 26 distinct serotypes. Here, we describe the development of a vaccine platform for BTV.
Brunet, Silvie +6 more
core +2 more sources
Journal of Clinical and Translational Science, 2017 OBJECTIVES/SPECIFIC AIMS: Determine whether children with solid tumors maintain intact protective immunity to live vaccines during cancer therapy and after completing cancer therapy (postTx). METHODS/STUDY POPULATION: We will perform a prospective cohort
Franchesca Garcia Robles +2 more
doaj +1 more source
Биопрепараты: Профилактика, диагностика, лечение, 2021 At present, there are not much data on the clinical use of live recombinant viral vector vaccines. Characteristics of new vaccines should be factored into requirements/recommendations for quality control, preclinical and clinical studies of vaccines in ...
L. M. Khantimirova +4 more
doaj +1 more source